STAINES, England - Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas Pharma Inc, one of the world’s top 20 pharmaceutical companies, can today announce details of an Astellas Changing Tomorrow Charity Award for Save the Children. The charity award is a funding programme designed to award organisations that help citizens, of all communities, realise their full potential and enhance their quality of life - both today and in the future.
The Astellas Changing Tomorrow Charity Awards complement the company’s existing ongoing Corporate Social Responsibility (CSR) programmes. These embody a global and European commitment to supporting medical research and education and uphold the company’s strong ethical principles. Among the main CSR-initiatives is the Astellas Pharma Europe Foundation, a registered charity with a long-term goal of providing support for programmes and activities that contribute to the advancement of an increasingly healthy society.
Recent beneficiaries of the Foundation include Save the Children UK in Liberia, who have been able to vaccinate more than 35,000 children against one of the biggest killers, measles and a further 45,000 children against other childhood diseases.
Susan Grant of Save the Children, Liberia, commented:
“The Astellas donation, spread over two years, has enabled Save the Children, Liberia to fund a lifesaving vaccination programmes. Not only did Save the Children and Astellas reach the target of vaccinating 35,000 children against Measles, but through Astellas’s generous donation Save the Children were able to purchase vehicles, including four motorbikes. This transportation provided Save the Children with vital access to remote and hard to reach rural areas, enabling us to provide basic healthcare and vaccinate a further 45,000 children against other childhood diseases.”
Mr Masao Yoshida, President and CEO of Astellas Pharma Europe Ltd, commented:
“Astellas has taken a long-term commitment to support Save the Children in projects that change the lives of children around the world. We have been very happy to contribute to such a worthwhile cause vaccinating children against deadly measles in Liberia.”
Save the Children, Cyclone Nargis Myanmar (Burma) emergency appeal was one of the four recipients of the Astellas Changing Tomorrow Charity Awards. Cyclone Nargis tore through Myanmar (Burma) on 3rd May 2008, killing almost 85,000 children and leaving more than 2.4 million homeless. Save the Children immediately started to raise funds for emergency aid to help the millions of people displaced by the devastating effect of the cyclone.
Andrew Kirkwood, Country Director Save the Children, Myanmar (Burma) commented:
“Astellas’ support has been invaluable and the funds provided really is saving lives and aiding the recovery of those most at need. Roads, buildings and crops were destroyed, water supplies contaminated and schools were brought to the ground. Children are extremely vulnerable in times of disaster, many became separated from their parents and families leaving them incredibly vulnerable to potentially fatal diseases - cholera, malaria, dysentery, pneumonia, skin infections and diarrhoea - neglect, abuse and trafficking. With Astellas’ generous donation to Save the Children we were able to reach 52,000 people in Myanmar (Burma) with essential lifesaving health and hygiene supplies. In this case Astellas’s donation has literally saved thousands of lives.”
Astellas Pharma Europe employs approximately 3,400 people in Central and Eastern Europe, as well as the Middle East and Africa. Dedicated to improving people’s lives around the world through the introduction of innovative and reliable pharmaceutical products, it has key strengths in the therapy areas of Transplantation, Urology, Dermatology and Anti-infectives.
Notes to Editors
About Astellas Pharma Europe Ltd.
Astellas Pharma Europe Ltd., located in the UK, is a European subsidiary of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organisation is committed to becoming a global company by combining outstanding R&D and marketing capabilities and continuing to grow in the world pharmaceutical market. Astellas Pharma Europe Ltd. is responsible for 20 affiliate offices located across Europe, the Middle East and Africa, an R&D site and three manufacturing plants with approximately 3,400 staff.
www.astellas.eu
Source: Astellas Pharma Europe Limited
For more information please contact: Corporate Communications, Astellas Pharma Europe Ltd., +44(0)1784-419-480, Astellas.European.Communications at eu.astellas.com
Related Press Releases
Astellas Pharma Europe Announces the International Foundation for Dermatology a Winner of the Changing Tomorrow 2009 AwardsNovember 2nd, 2009 STAINES, England - Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas Pharma Inc, one of the world's top 20 pharmaceutical companies, can today announce details of an Astellas Changing Tomorrow Charity Award for the International Foundation for Dermatology. The charity award is a funding programme designed to award organisations that help citizens, of all communities, realise their full potential and enhance their quality of life - both today and in the future.
ElcaMedia Named Silver Winner at 39th Annual Creativity AwardsOctober 7th, 2009 HOOFDDORP, The Netherlands - The 39th Annual Creativity Awards named ElcaMedia from The Netherlands as the Silver Award winner of the printed material category: B2B Brochure. This year, judges from some of the United States' most prestigious design firms evaluated the work produced by their peers and students.
Astellas Pharma Europe Announces Winners of the Changing Tomorrow 2009 AwardsSeptember 22nd, 2009 STAINES, England - Astellas Pharma Europe Ltd., the European subsidiary of Tokyo-based Astellas Pharma Inc., one of the world's top 20 pharmaceutical companies, has today announced the launch of the Astellas Changing Tomorrow Charity Awards. The charity award funding programme is designed to award organisations that help citizens of all communities realise their full potential and enhance their quality of life - both today and in the future.
The Iconic Samantha Fox & Marc Mysterio Partner With World Leading Digital Retailer Beatport for Exclusive Release on New Hit "Tomorrow"September 15th, 2009 LONDON - International Star House Musician Marc Mysterio (Can), Global Pop Icon Samantha Fox (UK), Amerada Music/World Class Records (Can), and Beatport are proud to announce the release of: 'Tomorrow' by Marc Mysterio ft Samantha Fox! "Tomorrow" was released worldwide on September 15th 2009 EXCLUSIVELY on the world's largest retailer for dance music, BEATPORT!
"Tomorrow" had its World airplay premiere on August 7th, 2009. Over that weekend; "Tomorrow" hit 100 million listeners!
Indeed, there has been a fantastic global reception! Massive Radio Networks have added it to their playlists (e.g.
Dutch Top Institute Pharma Attracts International InterestSeptember 9th, 2009 LEIDEN, The Netherlands - The Danish Council for Strategic Research is visiting the Dutch Top Institute Pharma (TI Pharma) on Thursday, September 10. The purpose of their visit is to learn about the unique Dutch approach on public-private cooperation and the concrete results that are being booked by this institute.
Invitation to the International Press Conference With Jermaine Jackson Presentation of the SAVE THE WORLD AWARDS 2009July 22nd, 2009 VIENNA, Austria -
- Andie MacDowell and Carl Lewis Will Attend
- Press Conference on July 24 at 11 p.m. at the Palais Niederosterreich in Vienna
WORLD AWARDS MEDIA, the State of Lower Austria and the SUPERFUND Investment Group invite you to the international press conference for the first SAVE THE WORLD AWARDS 2009 on July 24th at the Zwentendorf Nuclear Reactor.
NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM)June 21st, 2009 SAN MATEO, California and STAINES, England - Conference Call Today at 9:00am ET
- Covers Europe, Middle East and Africa
- Includes Licensing Option and Development Funding for NGX-1998
NeurogesX, Inc. (NASDAQ: NGSX) and Astellas Pharma Europe Ltd., (Astellas), the European subsidiary of Tokyo based Astellas Pharma Inc.
Innovative Treatment Approach Offers New Hope for Eczema Sufferers With Moderate to Severe Disease PROTOPIC(R)May 20th, 2009 PRAGUE - Ointment (Tacrolimus Monohydrate) in a New Twice-Weekly Regimen can Help Prevent Eczema Flares
Today sees the European launch of the first topical calcineurin inhibitor to be approved for the maintenance treatment of eczema to prevent flares and prolong flare-free intervals. PROTOPIC ointment (tacrolimus monohydrate) is already licensed to treat moderate and severe eczema (atopic dermatitis), often involving the treatment of flares as and when they occur.(*) It is now also approved for twice-weekly application to previously affected skin to prevent these exacerbations and prolong flare-free periods in PROTOPIC-responsive patients.(**) Clinical studies have shown that this new approach brings significant benefits with over 40% of patients with moderate to severe eczema remaining flare-free for at least a year.(1) Flares are known to place an enormous burden on patients.
The Astellas European Foundation Announces Winner of the 2009 Urology Prize FundMarch 23rd, 2009 STAINES, England - On Thursday 19th March 2009, at a ceremony held at the 24th annual EAU
congress in Stockholm, Sweden, the Astellas European Foundation announced the
winner of the 2009 Urology Prize. Dr Wouter Everaerts, MD and his team from
the KU Leuven, Belgium were awarded the prize in the amount of US$ 300,000 to
support their work in investigating the role of Transient Receptor Potential
(TRP) channels in Over Active Bladder (OAB).
By 2027 the Average Student Debt Could Reach GBP50,000March 22nd, 2009 LONDON - Responding to the announcement by the BBC, that many university
chancellors would like to see increases in tuition fees by between GBP5,000
and GBP20,000 a year, leading Child Trust Fund (CTF) Provider, The Children's
Mutual (www.thechildrensmutual.co.uk/) has calculated that families
may have to find GBP49,900 if youngsters decide to go to university in 18
years time. David White, Chief Executive of The Children's Mutual comments: "What is
clear from the research is that the cost of university is only going to
increase, it's just a case of by how much.
Related News
Maxygen CEO and CFO to leave Wednesday as part of expanded partnership with Astellas PharmaSeptember 30th, 2009 Maxygen says CEO and CFO will leave Sept. 30NEW YORK — Maxygen Inc.
NGO announces awards for senior citizensSeptember 30th, 2009 MUMBAI - An NGO working for senior citizen on Wednesday announced the winners of the awards for the year 2009. The annual awards honour dedicated to 10 elderly men and women will be presented by actress Hema Malini on Thursday.
Gibson pleaded with fire fighters to save Oscar statuettesFebruary 23rd, 2009 LONDON - Two time Oscar winner Mel Gibson pleaded with fire fighters to save his Oscar statuettes when his house in California was about to be burnt. Contactmusic.com reports that Gibson lives in Malibu which usually gets affected by fires.
With seven awards, it's been a 'fantastic' start: Priyanka ChopraApril 6th, 2009 NEW DELHI - It's not even halfway down the year, but Priyanka Chopra already has reasons enough to say 2009 has been 'fantastic' for her. The star has already walked away with seven awards including an international honour.
GVK Biosciences announces appointment of Gerhard N. Mayr to its Board of DirectorsAugust 4th, 2009 HYDERABAD - GVK Biosciences (GVK BIO) today announced the appointment of Gerhard N. Mayr to its Board of Directors.
Leona Lewis snubbed by Brit awardsJanuary 20th, 2009 LONDON - New British singing sensation Leona Lewis has been snubbed by the Brit Awards. 'It's a complete travesty, Lewis has been overlooked in her own country.
Nine Asian women declared winners of Asian Achievement awardsMay 21st, 2009 LONDON - Nine British women of Asian origin have been declared winners of the Asian Women of Achievement Awards for the year 2009. Businesswoman Vin Murria, who set up a foundation to support the education of children in India and was described by the judges as a "perfect ambassador and role model for Asian women in Britain", was declared the overall winner.
Britney Spears' 'Circus' tour announces summertime concerts in EuropeApril 30th, 2009 Britney Spears' 'Circus' tour will travel EuropeLOS ANGELES — Britney Spears is taking her "Circus" tour across Europe. The pop singer has announced new tour dates this summer in several countries, including Ireland, Sweden, France, Russia and Germany.
'Slumdog Millionaire' wins seven Bafta awardsFebruary 8th, 2009 LONDON - British filmmaker Danny Boyle's 'Slumdog Millionaire', a rags-to-riches tale of an improbable winner of game show 'Who Wants to be a Millionaire', has picked up seven honours at the British Film Academy Awards (Bafta) 2009. Boyle's film won seven trophies, including those for best film, best director and best original music score, the daily Telegraph reported on its website.
Britney Spears' 'Circus' tour announces more summertime concerts in EuropeApril 29th, 2009 Britney's 'Circus' tour traveling EuropeLOS ANGELES — Britney Spears is taking her "Circus" tour across Europe. The pop singer announced new tour dates this summer in several countries, including Ireland, Sweden, France, Russia, and Germany.
